Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Legal ‘Squishiness,’ DoJ Reorganization Could Shape Ad/Promo Enforcement Strategy
Oct 20 2025
•
By
Sue Sutter
Attorneys say some of the FDA warning and untitled letters raise "squishy" claims about misleading ads.
(Shutterstock)
More from Marketing & Advertising
More from FDLI